Scarica l'app Stockscreener
0.4404
0.09%
0.0004
Dopo l'orario di chiusura:
.42
-0.0204
-4.63%
Precedente Chiudi:
$0.44
Aprire:
$0.44
Volume 24 ore:
41,146
Relative Volume:
0.06
Capitalizzazione di mercato:
$3.54M
Reddito:
$122.10K
Utile/perdita netta:
$-13.77M
Rapporto P/E:
-0.5795
EPS:
-0.76
Flusso di cassa netto:
$-4.79M
1 W Prestazione:
-12.76%
1M Prestazione:
-10.67%
6M Prestazione:
-56.40%
1 anno Prestazione:
-25.98%
Intervallo 1D:
$0.425
$0.4573
Intervallo di 1 settimana:
$0.401
$0.524
Portata 52W:
$0.401
$4.2899
Ainos Inc Stock (AIMD) Company Profile
Nome
Ainos Inc
Settore
Industria
Telefono
858-869-2986
Indirizzo
AINOS, INC., SAN DIEGO
Ainos Inc Borsa (AIMD) Ultime notizie
Ainos stock plunges to 52-week low of $0.45 amid steep annual decline - Investing.com
Analyzing CONMED (NYSE:CNMD) & Ainos (OTCMKTS:AIMD) - Defense World
Ainos, Inc. (NASDAQ:AIMD) Short Interest Down 37.6% in October - Defense World
Ainos Expands Patent Portfolio With Strategic Shareholder’s Cutting-Edge Technology Assets - StockTitan
Ainos Highlights VELDONA Clinical Advancements and Market Potential in Water Tower Research Spotlight Podcast - StockTitan
Ainos Inc. secures exclusive patent rights in new deal - Investing.com
Ainos Inc. secures exclusive patent rights in new deal By Investing.com - Investing.com UK
Ainos (OTCMKTS:AIMD) Stock Price Down 8.7% – Here’s Why - Defense World
Ainos Leverages AI Nose for Safer, Smarter Factories - MSN
Financial Health Report: Ainos Inc (AIMD)’s Ratios Tell a Tale - The Dwinnex
Cutera (CUTR) Stock Drops 5.14% Amid Financial Challenges - GuruFocus.com
Ainos Inc. secures stockholder nod for special stock awards - Investing.com
AIMDWAinos, Inc. Warrants Latest Stock News & Market Updates - StockTitan
Ainos Inc (AIMD) Stock: A Year of Highs and Lows - The InvestChronicle
Ainos receives IRB nod for HIV-related oral wart trial - Investing.com India
Ainos, Inc. Receives IRB Approval From National Taiwan University Hospital for HIV-Oral Warts Clinical Trial, Highlighting Value of FDA-Designated Orphan Drug VELDONA - StockTitan
Ainos Spotlighted in Water Tower Research Report on VELDONA Clinical Study for Sjogren’s Syndrome - StockTitan
Ainos Announced Plan to Initiate Taiwan Clinical Study of VELDONA for Treating Sjögren's Syndrome, a Rare Disease With Limited Treatment Options - StockTitan
Esperion Therapeutics (NASDAQ:ESPR) versus Ainos (NASDAQ:AIMD) Critical Analysis - Defense World
Water Tower Research Highlights Ainos VELDONA Clinical Trial for HIV+ Patients with Oral Warts - StockTitan
AIMD stock touches 52-week low at $0.45 amid market challenges - Investing.com
Ainos set for clinical trial of HIV treatment at Taiwan hospital - Investing.com
AIMDAinos, Inc. Latest Stock News & Market Updates - StockTitan
Ainos Announced Plan to Initiate Taiwan Clinical Study for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA - StockTitan
Financial Review: Ainos (OTCMKTS:AIMD) versus Siemens Healthineers (OTCMKTS:SMMNY) - Defense World
Ainos (NASDAQ:AIMD) Shares Down 6.6% - Defense World
Ainos secures Taiwan patent for antiviral drug VELDONA - Investing.com
Ainos Secures Taiwan Invention Patent and Advances Global Patent Protection for VELDONA, a Breakthrough in Coronavirus Treatment and Prevention - Lelezard
Ainos to Participate in H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
Ainos (OTCMKTS:AIMD) Stock Price Up 6.1% - Defense World
Ainos CEO Highlights AI Nose Achievements and Upcoming 2H 2024 Milestones in Shareholder Letter - PharmiWeb.com
Ainos Inc (AIMD) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
Is the Ainos Inc (NASDAQ:AIMD) stock an investment opportunity? - US Post News
Ainos AI Nose achieves 79% accuracy in VOC detection - Investing.com India
Ainos Unveils AI Nose Breakthrough that Revolutionizes Smart Manufacturing Factory Automation and Manufacturing Safety - AccessWire
Ainos Unveils AI Nose Breakthrough that Revolutionizes - GlobeNewswire
Ainos reports 79% identification accuracy of AI Nose - TipRanks
Ainos, Inc. (NASDAQ:AIMD) Short Interest Update - Defense World
CXApp Inc [CXAI] moved down -25.76: Why It’s Important - The DBT News
Check out these key findings about Ainos Inc (AIMD) - SETE News
AIMD’s Stock Market Adventure: -70.20% YTD Growth Amidst Volatility - The InvestChronicle
AIMD’s price-to-book ratio: An indicator of the company’s performance - US Post News
Quarterly Metrics: Quick and Current Ratios for Ainos Inc (AIMD) - The Dwinnex
Why Is Ainos (AIMD) Stock Up 38% Today? - InvestorPlace
Ainos to Participate in Fireside Chat with Water Tower Research on August 22, 2024 - WICZ
Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket - Benzinga
Ainos acquires licences for ten patents to improve point-of-care testing - Yahoo Finance
Guangdong Baolihua New Energy Stock Co., Ltd. (000690.SZ) Latest Stock News & Headlines - Yahoo Finance
Ainos secures exclusive rights to 10 patents in healthcare tech - Investing.com India
Ainos Secures Tech Boost, Expands Portfolio and Settles Debt - TipRanks
Ainos secures exclusive rights to 10 patents in healthcare tech By Investing.com - Investing.com UK
Ainos Inc Azioni (AIMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.47%
1.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):